Forte Biosciences (FBRX) Operating Income (2016 - 2020)
Historic Operating Income for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to -$8.7 million.
- Forte Biosciences' Operating Income rose 4845.0% to -$8.7 million in Q1 2020 from the same period last year, while for Mar 2020 it was -$53.3 million, marking a year-over-year decrease of 693.28%. This contributed to the annual value of -$61.5 million for FY2019, which is 3414.83% down from last year.
- Latest data reveals that Forte Biosciences reported Operating Income of -$8.7 million as of Q1 2020, which was up 4845.0% from -$10.7 million recorded in Q4 2019.
- Over the past 5 years, Forte Biosciences' Operating Income peaked at $1.4 million during Q3 2018, and registered a low of -$19.1 million during Q4 2018.
- Over the past 5 years, Forte Biosciences' median Operating Income value was -$9.7 million (recorded in 2017), while the average stood at -$10.9 million.
- In the last 5 years, Forte Biosciences' Operating Income soared by 11465.54% in 2018 and then plummeted by 129992.99% in 2019.
- Quarter analysis of 5 years shows Forte Biosciences' Operating Income stood at -$8.0 million in 2016, then plummeted by 34.04% to -$10.7 million in 2017, then crashed by 78.8% to -$19.1 million in 2018, then soared by 43.99% to -$10.7 million in 2019, then increased by 18.73% to -$8.7 million in 2020.
- Its Operating Income stands at -$8.7 million for Q1 2020, versus -$10.7 million for Q4 2019 and -$17.1 million for Q3 2019.